Carlos Escobar
Overview
Explore the profile of Carlos Escobar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
258
Citations
825
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Escobar C, Saldana J, Merino J, Peinado R
Drugs Context
. 2025 Mar;
14.
PMID: 40078952
Background: This analysis assesses the effectiveness and tolerability profile of vericiguat in patients with heart failure with reduced ejection fraction (HFrEF) and implantable cardioverter-defibrillator, with an emphasis on the emergence...
2.
Escobar C, Palacios B, Villarreal M, Gutierrez M, Capel M, Hernandez I, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004910
To analyze clinical characteristics of non-anticoagulated subjects with major bleeding, and to determine the incidence of adverse events, healthcare resource utilization (HCRU) and associated costs following a major bleeding event....
3.
Bytyci I, Bytyqi S, Lewek J, Surma S, Bajraktari G, Henein M, et al.
Eur Heart J Open
. 2025 Feb;
5(1):oeaf001.
PMID: 39944782
Aims: Heterozygous familial hypercholesterolaemia (HeFH) is one of the most frequent monogenic disorders in the world, leading to premature atherosclerotic cardiovascular diseases. The aim of this meta-analysis was to evaluate...
4.
Escobar C, Aldeguer X, Vivas D, Manzano Fernandez S, Gonzalez Caballero E, Garcia Martin A, et al.
Expert Rev Cardiovasc Ther
. 2025 Feb;
23(1-2):23-34.
PMID: 39915986
Introduction: The pathophysiology of cardiovascular diseases encompasses a complex interplay of genetic and environmental risk factors. Even if traditional risk factors are treated to target, there remains a residual risk....
5.
Costa A, Mendes I, Lage J, Moniz M, Amorim C, Nunes P, et al.
Mediterr J Hematol Infect Dis
. 2025 Jan;
17(1):e2025011.
PMID: 39830790
Background: Red Blood Cell Exchange (RBCX) is a common treatment for pediatric sickle cell disease (SCD). Since inflammation with elevated proinflammatory cytokines plays a crucial role in SCD, this study...
6.
Gomez Doblas J, Garcia-Moll X, Bover Freire R, Juanatey C, Morillas M, Munoz A, et al.
Future Cardiol
. 2024 Oct;
20(13):695-708.
PMID: 39439239
Management of oral anticoagulation (OAC) can be challenging, such as in complex cases of nonvalvular atrial fibrillation (NVAF). A Delphi study comprising two rounds was used for gathering expert opinion...
7.
Escobar C, Mazon P, Rivadulla C, Chandrappa S
Expert Rev Cardiovasc Ther
. 2024 Oct;
22(10):575-587.
PMID: 39435482
Introduction: Eprosartan is an angiotensin receptor blocker (ARB) used for management of essential hypertension. With unique pharmacological characteristics, dual action mechanism, and clinical effectiveness, eprosartan offers additional advantages over other...
8.
Carvalho M, Guerra A, Moniz M, Escobar C, Nunes P, Bento V, et al.
Cureus
. 2024 Sep;
16(8):e66451.
PMID: 39246893
Background Painful procedures in the pediatric emergency department often require the use of sedation and analgesia to ensure adequate pain control, a right of children and adolescents. This study aims...
9.
Vasco J, Albuquerque F, Costa F, Dias Curado A, Escobar C
Acta Med Port
. 2024 Aug;
37(11):802-804.
PMID: 39177009
The idiopathic systemic capillary leak syndrome is characterized by recurrent episodes of hypovolemia, with an unknown cause, presenting as a distributive and hypovolemic shock, due to fluid loss to the...
10.
Fuster V, Escobar C
Rev Med Chil
. 2024 Aug;
151(9):1143-1152.
PMID: 39093151
Background: Evidence suggests many dyslipidemic patients do not reach target low-density lipoprotein and cholesterol (LDL-C) levels in primary health care. Objective: We aimed to describe the pharmacologic therapeutic management of...